
MLTX Stock Price
MoonLake Immunotherapeutics
$11.08
+$0.29(+2.69%)
37
Overall
60
Value
25
Tech
28
Quality
Market Cap
$942.98M
Volume
803.94K
52W Range
$9.46 - $23.29
Target Price
$34.93
MLTX stock price is $11.08 (+2.69% on the day), giving MoonLake Immunotherapeutics a market cap of $942.98M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
MLTX Stock Overview
- Price
- $11.08
- Previous close
- $10.79
- Open
- $10.90
- Market cap
- $942.98M
- 52-week range
- $9.46 - $23.29
- 1-year price target
- $34.93
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- Nasdaq
- MarketXLS Rank
- 37
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics, a clinical stage biopharmaceutical company, engages in developing therapies. The company develops Sonelokimab, a novel tri-specific investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLTX | $11.08 | +2.7% | 803.94K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get MoonLake Immunotherapeutics Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW